1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends

EpiCast Report: Celiac Disease - Epidemiology Forecast to 2023

  • November 2014
  • 45 pages
  • GlobalData
Report ID: 2483718

Summary

Table of Contents

Search Inside

EpiCast Report: Celiac Disease - Epidemiology Forecast to 2023

Summary

Celiac disease is an autoimmune disease that occurs in individuals who consume gluten-containing foods but are intolerant to gluten, a protein found in many grains, such as wheat, rye, and barley. In celiac disease, the body’s immune system attacks and destroys the villi of the small intestine and thus interferes with nutrient absorption. Celiac disease can be difficult to diagnose because the symptoms vary between individuals and are non-specific, such as abdominal bloating and pain, diarrhea, constipation, and weight loss. Short-term malicious effects of untreated celiac disease include malnutrition, vitamin and mineral deficiency, and anemia, whereas long-term effects include bone diseases, cancers, and liver diseases. Celiac disease can arise in individuals of all ages and current epidemiological studies estimate that celiac disease affects around 1% of the population in western countries, with a range of between 0.3-2.7%.

GlobalData epidemiologists forecast that the number of total prevalent cases of celiac disease in the 6MM is expected to grow to 8.08 million cases in 2023 at a rate of 3.92% per year during the forecast period. The number of diagnosed prevalent cases in the 6MM is expected to increase by 4.61% over the next decade to 1.11 million cases in 2023.

GlobalData’s forecast and analysis is based on a thorough literature review and from primary research results. GlobalData epidemiologists carefully reviewed and selected secondary research studies and validated the findings with primary research. GlobalData epidemiologists maintained a consistent case-finding definition and forecasting methodology for celiac disease throughout the 6MM, thus allowing for a meaningful comparison of the total and diagnosed prevalent cases of celiac disease in these markets. The total prevalent cases of celiac disease are also segmented by sex, thus providing a detailed analysis of the patient population characteristic of celiac disease. Furthermore, GlobalData epidemiologists also provided a realistic trend forecast for the total and diagnosed prevalence of celiac disease based on insights gained through the analysis of historical data.

Scope

- The celiac disease EpiCast Report provide an overview of the risk factors, comorbidities, and the global and historical trends for celiac disease in the six major markets (6MM) (US, France, Germany, Italy, Spain, and UK). In addition, the report also includes a 10-year epidemiological forecast for the total prevalent cases of celiac disease segmented by sex and age (0-19 years, 20-29 years, 30-39 years, 40-49 years, 50-59 years, 60-69 years, and =70 years), and a 10-year epidemiological forecast for the diagnosed prevalent cases of celiac disease in the 6MM.
- The celiac disease epidemiology report is written and developed by Masters- and PhD-level epidemiologists.
- The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 6MM.

Reasons to buy

- Develop business strategies by understanding the trends shaping and driving the global celiac disease market.
- Quantify patient populations in the global celiac disease market to improve product design, pricing, and launch plans.
- Organize sales and marketing efforts by identifying the sex and age groups that present the best opportunities for celiac disease therapeutics in each of the markets covered.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

Veronica helps you find the right report:

Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

Purchase Reports From Reputable Market Research Publishers

OpportunityAnalyzer: NASH - Opportunity Analysis and Forecasts to 2026

  • $ 10995
  • Industry report
  • May 2017
  • by GlobalData

OpportunityAnalyzer: NASH - Opportunity Analysis and Forecasts to 2026 Summary Nonalcoholic steatohepatitis (NASH) (ICD-10-CM = K75.81) is a condition that develops as a subgroup of nonalcoholic fatty ...

Italy General Surgery Outlook to 2023 - Airway Stenting Procedures, Bariatric Surgery Procedures, Biopsy Procedures, Female Sterilization Procedures, Gastric Balloon Procedures, Enteral Stenting Procedures and Others

  • $ 3995
  • Industry report
  • July 2017
  • by GlobalData

Italy General Surgery Outlook to 2023 - Airway Stenting Procedures, Bariatric Surgery Procedures, Biopsy Procedures, Female Sterilization Procedures, Gastric Balloon Procedures, Enteral Stenting Procedures ...

South Korea General Surgery Outlook to 2023 - Airway Stenting Procedures, Bariatric Surgery Procedures, Biopsy Procedures, Female Sterilization Procedures, Gastric Balloon Procedures, Enteral Stenting Procedures and Others

  • $ 3995
  • Industry report
  • July 2017
  • by GlobalData

South Korea General Surgery Outlook to 2023 - Airway Stenting Procedures, Bariatric Surgery Procedures, Biopsy Procedures, Female Sterilization Procedures, Gastric Balloon Procedures, Enteral Stenting ...


ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.